Ostrow D G, Pandey G N, Davis J M, Hurt S W, Tosteson D C
Am J Psychiatry. 1978 Sep;135(9):1070-8. doi: 10.1176/ajp.135.9.1070.
The in vivo RBC/plasma Li+ ratio is determined by the equilibrium between Li+ influx (ouabain-sensitive Na+-K+ pump and ouabain-insensitive leakage pathways) and Li+ efflux (phloretin-sensitive Li+-Na+ counterflow). A study of RBC Li+ transport via these pathways showed that a deficiency of Li+-Na+ counterflow was responsible for the high in vivo ratio (1:1) observed in a manic patient. This defect was related to an alteration in the membrane Na+ exchange system and was under genetic control. The level of counterflow before lithium therapy was an excellent predictor (r = .88) of the in vivo Li+ ratio and was deficient in approximately one-fourth of manic-depressive patients but not in controls, schizophrenics, or unipolar depressed patients.
体内红细胞/血浆锂离子(Li⁺)比率由Li⁺流入(哇巴因敏感的钠钾泵和哇巴因不敏感的渗漏途径)与Li⁺流出(根皮素敏感的Li⁺-Na⁺逆向流动)之间的平衡决定。一项关于通过这些途径进行红细胞Li⁺转运的研究表明,Li⁺-Na⁺逆向流动的缺乏是导致一名躁狂症患者体内观察到的高比率(1:1)的原因。这种缺陷与膜钠交换系统的改变有关,并且受遗传控制。锂治疗前逆向流动的水平是体内Li⁺比率的一个极佳预测指标(r = 0.88),在大约四分之一的躁郁症患者中逆向流动水平不足,但在对照组、精神分裂症患者或单相抑郁症患者中并非如此。